Wockhardt, Alembic challenge NPPA's price revision move in D
Pharmaceutical companies Wockhardt and Alembic have challenged in the Delhi High Court the National Pharmaceutical Pricing Authority's recent moves related to fixation and revision of prices of medicines. This comes closely after the Mumbai High Court granted an interim order to members of two pharma lobby groups opposing the drug pricing watchdog for the same reason.

Read more at:
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/wockhardt-alembic-challenge-nppas-price-revision-move-in-delhi-hc/articleshow/52247115.cms
Like
Comment
Share